Diseases

Alcohol-Related Liver Disease

Hepatitis A & E

Hepatitis B

Hepatitis C

Hepatocellular Carcinoma

Intrahepatic Cholestasis

Liver Abscess

Neonatal Jaundice

Nonalcoholic Fatty Liver Disease

Primary Biliary Cholangitis

Product Highlight - Ravida

13 Sep 2022

Ravidasvir 200 mg tab

Product Highlight - OZEMPIC

16 Sep 2020

OZEMPIC – Semaglutide 1.34 mg/mL soln for inj

Relationship between tumour response to systemic therapy and overall survival in unresectable hepatocellular carcinoma

Dr Raghav Sundar, 09 Sep 2019

Overall survival (OS) is currently the primary criteria in assessing the efficacy of a cancer treatment. Dr Raghav Sundar, a consultant medical oncologist at the National University Hospital, Singapore, details the crucial role played by tumour response in evaluating treatment efficacy, with a focus on the multiple kinase inhibitor lenvatinib in the treatment of hepatocellular carcinoma (HCC).